Navigation Links
Onyx in Medical News

Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer

WAYNE, N.J. and EMERYVILLE, Calif., June 1 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar(R) (sorafenib) tablets...

AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis

NEW YORK, May 29 /PRNewswire/ -- How much do you know about hepatitis? Here's more on the importance of liver health and education. Listen to this report from Bayer Healthcare and Onyx Pharmaceuticals at: http://inr.mediaseed.tv/oneClip_C/?feed=Ybx9S3lY7r__59P8wyiGqelU6PdFR6h9 Reg...

Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results

First Full Year of Profitability with GAAP Earnings Per Share of $0.03 2008 Nexavar Net Sales of $678 Million Represents 82% Growth Over 2007 EMERYVILLE, Calif., Feb. 23 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today reported its financial results for the f...

S*BIO Announces Collaboration with Onyx for JAK2 Inhibitors in the North American and European Markets

S*BIO Receives $25 Million Upfront Payment and Equity Investment and Eligible to Receive Additional $525 Million in Option & License Fees and Milestone Payments SINGAPORE, Jan. 6 /PRNewswire/ -- S*BIO Pte Ltd today announced that the company has entered into a Development Collaboration, a...

Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors

New Survey Quantifies Misperceptions about Liver Cancer in the United States WAYNE, N.J. and EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- A new survey of more than 1,000 American adults revealed that general knowledge regarding liver cancer risk factor...

Revolutionary New Technique Uses Onyx to Fill Hard-To-Treat Aneurysms

Dr. Demetrius Lopes one of first in country to use new technique CHICAGO, March 26 /PRNewswire/ -- It has been quite a week for aneurysm patient Diane Long, of Homewood, Illinois. On Sunday, she struggled with double vision because of a large aneurysm in her brain compressing a nerve that ...

Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer

Bayer HealthCare Pharmaceuticals Inc. (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a Supplemental New Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with he...

Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors

...or to successfully selling the company to Bristol-Myers Squibb in 2008. Ms. Kim's additional industry experience includes senior positions at Affymax, onyx Pharmaceuticals, Protein Design Labs and Chiron Corporation. In addition to her industry experience, Ms. Kim also recently served as Chief Program Off...

Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer

...FirstCall/ -- Bayer HealthCare Pharmaceuticals and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today anno...eting. "Based on these encouraging data, onyx and Bayer are evaluating various strategies for Ne...preventing and treating diseases. About onyx Pharmaceuticals, Inc. ...

Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer

...8 /PRNewswire-FirstCall/ -- Bayer HealthCare LLC., onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ), OSI Pharm...e are pleased to collaborate with Roche, Bayer and onyx to explore Tarceva in hepatocellular carcinoma, a ...-developed by Bayer Healthcare Pharmaceuticals and onyx Pharmaceuticals, Inc., is being evaluated by the c...
Onyx in Medical Technology

Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer

WAYNE, N.J. and EMERYVILLE, Calif., Aug. 21 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced the companies have begun enrolling patients in the STORM Sorafenib as Adjuvant Treatment in the Prevention of Recurrence ...

Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint

...FirstCall/ -- Bayer HealthCare Pharmaceuticals and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today anno...ocol and statistical analysis plan. Bayer and onyx will further review the findings of this analysis ...ing, preventing and treating diseases. About onyx Pharmaceuticals, Inc. ...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

...3 * Sutent(R) is a registered trademark of Pfizer Inc. ** Nexavar(R) is a registered trademark of Bayer HealthCare Pharmaceuticals, Inc. and onyx Pharmaceuticals. *** Data from RECORD-1 study findings presented at the 33rd European Society for Medical Oncology Congress. ...

MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer

...or circumstances after the date of this news release or to reflect the occurrence of subsequent events Nexavar(R) is a registered trademark of onyx Pharmaceuticals, Inc. and Bayer HealthCare Pharmaceuticals, Inc ...

The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer

...FirstCall/ -- Bayer HealthCare Pharmaceuticals and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announc...m or call 1.866.NEXAVAR (1.866.639.2827). About onyx Pharmaceuticals, Inc. onyx Pharmaceuticals, Inc. is a biopharmaceutical compa...

New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting

...all/ -- Bayer HealthCare Pharmaceuticals, Inc. and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today annou...cutive vice president and chief medical officer of onyx Pharmaceuticals. "We are committed to maximizing t...gnosing, preventing and treating diseases. About onyx Pharmaceuticals, Inc. ...

Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study

...all/ -- Bayer HealthCare Pharmaceuticals, Inc. and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today annou...gnosing, preventing and treating diseases. About onyx Pharmaceuticals, Inc. onyx Pharmaceuticals, Inc. is a biopharmaceutical compa...

Nexavar First FDA-Approved Drug Therapy for Liver Cancer

...FirstCall/ -- Bayer HealthCare Pharmaceuticals and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announc...chairman, president and chief executive officer of onyx Pharmaceuticals, Inc. "This second approval for Ne...om or call 1.866.NEXAVAR (1.866.639.2827). About onyx Pharmaceuticals, Inc. ...

Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial

...Bayer HealthCare Pharmaceuticals (NYSE: BAY ) and onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today annou...om or call 1.866.NEXAVAR (1.866.639.2827). About onyx Pharmaceuticals, Inc. onyx Pharmaceuticals, Inc. is a biopharmaceutical compa...

Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at AACR

...d herein by reference. Idera disclaims any intention or obligation to update any forward-looking statements. Nexavar(R) is a registered trademark of onyx Pharmaceuticals and Bayer Corporation. Contact Idera Pharmaceuticals, Inc. Kelly Luethje, 617-679-5519 (function() { var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true; po.src = 'https://apis.google.com/js/plusone.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s); })();